Skip to contentV
Vaxart, Inc.
V
VXRTVaxart, Inc. Q3 2022 · 10-Q
Revenue$0.00$0.00−100.0% vs Q3 2021 Net Income-$29.31M-$29.31MN/M vs Q3 2021 EPS, diluted—
Operating Income-$29,426,000N/M Operating Cash Flowderived-$14,615,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaxart, Inc. · CIK 72444 · Engraved from SEC EDGAR
Free Cash Flowderived-$16,643,000N/M ended Sep 30, 2022 · filed Nov 9, 2022 · 40 d after period end